Fluzoparib Neoadjuvant Therapy for Ovarian Cancer
Clinical trial NCT06541314 · UNKNOWN
Trial details
- NCT number
- NCT06541314
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-18
- Primary completion
- 2026-05-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.